Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Exelixis Inc. Common Stock (EXEL) vs iShares Silver Trust (SLV) Price & Performance

Exelixis Inc. Common StockTrade
iShares Silver TrustTrade

Price performance (Past 24H)

Key statistics

Exelixis Inc. Common Stock vs iShares Silver Trust — how do they compare? Exelixis Inc. Common Stock trades at $58.58 (market cap $14.48B), while iShares Silver Trust trades at $54.6 (market cap $29.58B). The key difference: iShares Silver Trust is far larger — about 2× Exelixis Inc. Common Stock's market cap, and Exelixis Inc. Common Stock is trading nearer its 52-week high, iShares Silver Trust nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Exelixis Inc. Common Stock for 0 Days and iShares Silver Trust for 89 Days on average.

EXELSLV
Market Cap
$14.48B$29.58B
Volume
2,374,77420,364,955
Sector
Health—
52-Week High
$59.13$105.57
52-Week Low
$34.54$42.40
Typical Hold Time
0 Days89 Days
Enterprise Value
$13.81B—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Exelixis Inc. Common Stock

No Aura AI signal available yet.

iShares Silver Trust

SLV (iShares Silver Trust) is trading at $53.82, down 2.94% amid broader precious metals pressure from rising Treasury yields and Fed rate hike expectations. The ETF shows minimal operational activity with $0 revenue but maintains a strong balance sheet with $13.41 billion in assets against negligible liabilities. Technical indicators signal bearish momentum with moving averages overwhelmingly negative, though RSI levels suggest potential oversold conditions.

While silver faces near-term headwinds from monetary policy, structural demand from industrial applications and inflation hedging provides long-term support. Key risks include Fed policy volatility and dollar strength, but the trust's pure-play silver exposure offers strategic diversification. Current levels may present accumulation opportunities for investors with multi-year horizons.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

EXEL
100% Buy0% Sell
Avg holding period · 0 Days
SLV
69% Buy31% Sell
Avg holding period · 89 Days

About Exelixis Inc. Common Stock

Exelixis develops and commercializes medicines for cancer. Its research focuses on targeted therapies for oncology.

Read more on EXEL →

About iShares Silver Trust

The ETF seeks to reflect such performance before payment of the ETF's expenses and liabilities. It is not actively managed. The ETF does not engage in any activities designed to obtain a profit from, or to ameliorate losses caused by, changes in the price of silver.

Read more on SLV →